Van Andel Institute scientists have for the first time described the near-atomic level structure of a molecular pathway that plays critical roles in human development, blood pressure regulation, inflammation and cell death. The findings were published today in the journal Nature.
- Addition of sintilimab to pemetrexed and platinum improved progression-free survival
- Phase 3 eXalt3 study shows significantly longer progression-free survival
- checkmate 743 shows that dual immunotherapy, nivolumab + ipilimumab
- Scientists discover curious clues in the war between cf bacteria
- Predicting drought in the American West just got more difficult